Drugmakers want more clarity from the Trump administration on the potential pharmaceutical tariffs, which some companies warn ...

Feb 18 (Reuters) - Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who accused the company of conspiring with industry rivals ...

Swiss-headquartered Sandoz, which spun off from Novartis in 2023, is one of the world's largest makers of generic and biosimilar drugs. The company sells anti-infectives and generic narcotics for ...

Sandoz Group said it would pay $275 million to settle claims from some plaintiffs in a generics drug pricing antitrust lawsuit in the U.S. The Swiss generics-medicine company said Tuesday that it ...

Sandoz discusses PBMs, generics and the 340B drug pricing program in its new report titled, Solving American’s Drug Shortage Dilemma, For Good. Noting that despite successes and benefits ...

ZURICH, Jan 22 (Reuters) - Sandoz SDZ.S on Monday announced a deal to buy Cimerli, a biosimilar drug to treat vision impairment and loss, from Coherus BioSciences Inc. for $170 million.

Sandoz is one of the largest off-patent pharmaceutical manufacturers in the world. It generates roughly 75% of sales from generic drugs and the remainder from biosimilars and it has a significant ...

Your doctor has weighed the risks of you taking Cyclosporin Sandoz against the benefits they expect it will have for you. If you have any concerns about taking this medicine, ask your doctor or ...